The Promise and Perils of Cellular TherapiesJuly 16, 2019 |
New “living drugs”—made from a patient’s own cells—can cure once incurable cancers. But can we afford them?
Quick Read
For Some Critical Drugs, Low Prices Lead to ScarcityJune 19, 2019 |
Shortages of “supportive care” drugs, for chemotherapy-induced nausea or to protect the kidneys, can delay cancer treatments, said Yoram Unguru, a pediatric oncologist & bioethicist at Sinai and the Johns Hopkins Berman Institute of Bioethics. When he gets the hospital’s list of shortages, “I scream, I shout, I shake my head”
Quick Read
Federal prosecutors accused the company of illegally marketing its powerful fentanyl painkiller and of defrauding government health care programs
Quick Read
Cancer drugs that speed onto the market based on encouraging preliminary studies often don’t show clear benefits when more careful follow-up trials are done, according to research published Tuesday
Quick Read
The Birth-Tissue ProfiteersMay 7, 2019 |
How well-meaning donations end up fueling an unproven, virtually unregulated $2 billion stem cell industry
Quick Read
Summer BummerApril 30, 2019 |
The snake struck a 9-year-old hiker at dusk on a nature trail. The outrageous bills struck her parents a few weeks later
Quick Read
With much fanfare, federal officials required hospitals nationwide this year to post their “list” prices online. But it’s not yet clear how many are doing it, even as the government has taken the rare step of asking consumers to monitor hospital compliance.
Quick Read
As pharmaceutical companies seek to profit from the curative wonders of human feces, doctors worry about new regulations, higher prices and patients attempting DIY cures
Quick Read